menu
    • menu

    API Export of Camonsertib obtained from Indian Customs Trade Statistics

    Client Email Product
    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    Bora Pharmaceuticals- Making success more certain.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Minakem offers CDMO services for API & HPAPI, generics, regulatory expertise, track record performance & FDA & GMP certifications.

    Virtual Booth

    Contact Supplier

    Axplora- The partner of choice for complex APIs.

    Virtual Booth

    Contact Supplier

    Fareva is a one-stop-shop for API/HPAPI, OSD & Sterile products, is USFDA, EMA and PMDA-inspected and has multiple NDA & ANDA filings.

    Virtual Booth

    Contact Supplier

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass

    Synopsis

    Product SearchProduct Search

    Synopsis

    ACTIVE PHARMA INGREDIENTS

    0

    API Suppliers

    API Suppliers

    0

    USDMF

    US DMFs Filed

    0

    CEP/COS

    CEP/COS Certifications

    0

    JDMF

    JDMFs Filed

    0

    EU WC

    EU WC

    0

    KDMF

    KDMF

    0

    NDC API

    NDC API

    0

    VMF

    NDC API

    0

    Listed Suppliers

    Other Suppliers

    API REF. PRICE (USD/KG)

    $
    $ 0

    MARKET PLACE

    0

    API

    0

    FDF

    0INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    0

    FDF Dossiers

    FDF Dossiers

    0

    FDA Orange Book

    FDA (Orange Book)

    0

    Europe

    Europe

    0

    Canada

    Canada

    0

    Australia

    Australia

    0

    South Africa

    South Africa

    0

    Listed Dossiers

    Listed Dossiers

    10DRUGS IN DEVELOPMENT

    FDF Dossiers

    DRUG PRODUCT COMPOSITIONS

    REF. STANDARDS OR IMPURITIES

    0

    EDQM

    0

    USP

    0

    JP

    0

    Others

    PATENTS & EXCLUSIVITIES

    0

    US Patents

    0

    US Exclusivities

    0

    Health Canada Patents

    DIGITAL CONTENT

    0

    Data Compilation #PharmaFlow

    0

    Stock Recap #PipelineProspector

    0

    Weekly News Recap #Phispers

    3

    News #PharmaBuzz

    GLOBAL SALES INFORMATION

    US Medicaid

    NA

    Annual Reports

    NA

    Finished Drug Prices

    NA

    0RELATED EXCIPIENT COMPANIES

    0EXCIPIENTS BY APPLICATIONS

    Chemistry

    Click the arrow to open the dropdown
    read-moreClick the button for full data set
    read-moreClick the button for full data set
    Also known as: Rp-3500, 2417489-10-0, Rp3500, Camonsertib [inn], Camonsertib [usan], Camonsertib (rp-3500)
    Molecular Formula
    C21H26N6O3
    Molecular Weight
    410.5  g/mol
    InChI Key
    YIHHYCIYAIVQKX-YNOVCBQDSA-N
    FDA UNII
    S1Z7Y5G56T
    Camonsertib
    Camonsertib is an orally available inhibitor of ataxia telangiectasia and Rad3 related (ATR) kinase, with potential antineoplastic activity. Upon oral administration, camonsertib selectively targets and inhibits ATR activity and blocks the downstream phosphorylation of the serine/threonine protein kinase checkpoint kinase 1 (CHK1). This prevents ATR-mediated signaling, which results in the inhibition of DNA damage checkpoint activation, the disruption of DNA damage repair, and the induction of tumor cell apoptosis. ATR, a serine/threonine protein kinase upregulated in a variety of cancer cell types, plays a key role in DNA repair, cell cycle progression and survival. It is activated by DNA damage caused during DNA replication-associated stress.
    1 2D Structure

    Camonsertib

    2 Identification
    2.1 Computed Descriptors
    2.1.1 IUPAC Name
    (1R,5S)-3-[6-[(3R)-3-methylmorpholin-4-yl]-1-(1H-pyrazol-5-yl)pyrazolo[3,4-b]pyridin-4-yl]-8-oxabicyclo[3.2.1]octan-3-ol
    2.1.2 InChI
    InChI=1S/C21H26N6O3/c1-13-12-29-7-6-26(13)19-8-17(21(28)9-14-2-3-15(10-21)30-14)16-11-23-27(20(16)24-19)18-4-5-22-25-18/h4-5,8,11,13-15,28H,2-3,6-7,9-10,12H2,1H3,(H,22,25)/t13-,14-,15+,21?/m1/s1
    2.1.3 InChI Key
    YIHHYCIYAIVQKX-YNOVCBQDSA-N
    2.1.4 Canonical SMILES
    CC1COCCN1C2=NC3=C(C=NN3C4=CC=NN4)C(=C2)C5(CC6CCC(C5)O6)O
    2.1.5 Isomeric SMILES
    C[C@@H]1COCCN1C2=NC3=C(C=NN3C4=CC=NN4)C(=C2)C5(C[C@H]6CC[C@@H](C5)O6)O
    2.2 Other Identifiers
    2.2.1 UNII
    S1Z7Y5G56T
    2.3 Synonyms
    2.3.1 Depositor-Supplied Synonyms

    1. Rp-3500

    2. 2417489-10-0

    3. Rp3500

    4. Camonsertib [inn]

    5. Camonsertib [usan]

    6. Camonsertib (rp-3500)

    7. Atr Inhibitor 4;camonsertib

    8. S1z7y5g56t

    9. Chembl5095260

    10. Schembl23515008

    11. Schembl23515085

    12. Gtpl12073

    13. Rp 3500 [who-dd]

    14. Rp 3500

    15. 8-oxabicyclo[3.2.1]octan-3-ol, 3-[6-[(3r)-3-methyl-4-morpholinyl]-1-(1h-pyrazol-3-yl)-1h-pyrazolo[3,4-b]pyridin-4-yl]-, (3-endo)-

    16. Ex-a6416

    17. Nsc841442

    18. Nsc-841442

    19. Ms-27079

    20. Cs-0226170

    21. F83116

    22. (1r, 5s)-3-[6-[(3r)-3-methylmorpholin-4-yl]-1-(1h-pyrazol-5-yl)pyrazolo[3, 4-b]pyridin-4-yl]-8-oxabicyclo[3.2.1]octan-3-ol

    23. (1r,3r,5s)-3-{6-[(3r)-3-methylmorpholin-4-yl]-1-(1hpyrazol-3-yl)-1h-pyrazolo[3,4-b]pyridin-4-yl}-8-oxabicyclo[3.2.1]octan-3-ol

    24. (1r,3r,5s)-3-6-[(3r)-3-methylmorpholin-4-yl]-1-(1hpyrazol-3-yl)-1h-pyrazolo[3,4-b]pyridin-4-yl-8-oxabicyclo[3.2.1]octan-3-ol

    25. (1r,5s)-3-[6-[(3r)-3-methylmorpholin-4-yl]-1-(1h-pyrazol-5-yl)pyrazolo[3,4-b]pyridin-4-yl]-8-oxabicyclo[3.2.1]octan-3-ol

    2.4 Create Date
    2021-08-21
    3 Chemical and Physical Properties
    Molecular Weight 410.5 g/mol
    Molecular Formula C21H26N6O3
    XLogP31.6
    Hydrogen Bond Donor Count2
    Hydrogen Bond Acceptor Count7
    Rotatable Bond Count3
    Exact Mass g/mol
    Monoisotopic Mass g/mol
    Topological Polar Surface Area101
    Heavy Atom Count30
    Formal Charge0
    Complexity628
    Isotope Atom Count0
    Defined Atom Stereocenter Count3
    Undefined Atom Stereocenter Count0
    Defined Bond Stereocenter Count0
    Undefined Bond Stereocenter Count0
    Covalently Bonded Unit Count1

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search